Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rγnull mice generate a faster and more efficient disease compared to other NOD/scid-related strains-Reference-Cited by-同舟云学术

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rγnull mice generate a faster and more efficient disease compared to other NOD/scid-related strains

Published:2008-11-01 Issue:9 Volume:123 Page:2222-2227
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Agliano Alice,Martin-Padura Ines,Mancuso Patrizia,Marighetti Paola,Rabascio Cristina,Pruneri Giancarlo,Shultz Leonard D.,Bertolini Francesco

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Humanized mice in translational biomedical research;Shultz;Nat Rev Immunol,2007

2. Immune-deficient mouse models for analysis of human stem cells;Meyerrose;Biotechniques,2003

3. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat Med,1997

4. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects;Hudson;Leukemia,1998

5. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/β2-microglobulin(null) mice;Kawano;Leukemia,2005

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Next top” mouse models advancing CTCL research;Frontiers in Cell and Developmental Biology;2024-04-10

2. Enzalutamide induces cytotoxicity in desmoplastic small round cell tumor independent of the androgen receptor;Communications Biology;2024-04-04

3. Animal model considerations for chordoma research: reproducing the tumor microenvironment in vivo with humanized mice;Frontiers in Oncology;2024-03-13

4. Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects;Methods in Molecular Biology;2024

5. Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development;Frontiers in Immunology;2023-11-30